dc.contributor.author | Snowsill, TM | |
dc.date.accessioned | 2017-02-15T11:58:32Z | |
dc.date.issued | 2017-02-15 | |
dc.description.abstract | This is an economic model, developed in Microsoft Excel, for evaluating the cost-effectiveness (cost-utility) of different immunosuppressive regimens for adult kidney transplant recipients. This is the Assessment Group economic evaluation for the National Institute for Health and Care Excellence (NICE) Technology Appraisal guidance in development: Kidney transplantation (adults) - immunosuppressive therapy (review of TA 85) [ID456]. It produces the deterministic base case analysis for the model, and the probabilistic sensitivity analysis (PSA) as reported to NICE and in the monograph [Jones-Hughes T, Snowsill T, Haasova M, et al. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic evaluation. Health Technology Assessment 2016;20(62)]. It includes the specific PSA dataset upon which the results were based, but can be used to generate a new PSA dataset. | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/25885 | |
dc.language.iso | en | en_GB |
dc.publisher | University of Exeter | en_GB |
dc.relation.url | https://doi.org/10.3310/hta20610 | en_GB |
dc.subject | Multiple Technology Assessment (MTA) | en_GB |
dc.subject | Tacrolimus | en_GB |
dc.subject | Sirolimus | en_GB |
dc.subject | Mycophenolate mofetil | en_GB |
dc.subject | Mycophenolate sodium | en_GB |
dc.subject | Everolimus | en_GB |
dc.subject | Belatacept | en_GB |
dc.subject | Basiliximab | en_GB |
dc.subject | Rabbit anti-thymocyte globulin | en_GB |
dc.subject | Decision model | en_GB |
dc.title | Immunosuppressive therapy for kidney transplantation in adults: Economic model (dataset) | en_GB |
dc.type | Dataset | en_GB |
dc.date.available | 2017-01-23 | en_GB |
dc.date.available | 2017-02-15T11:58:32Z | |